Citation Impact
Citing Papers
Environmental biodiversity, human microbiota, and allergy are interrelated
2012
Mutagenic potency of Helicobacter pylori in the gastric mucosa of mice is determined by sex and duration of infection
2010
The gut microbiota and host health: a new clinical frontier
2015 Standout
Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report
2016 Standout
Management of Helicobacter pylori infection—the Maastricht IV/ Florence Consensus Report
2012 Standout
Immune Cell Profiling of IFN-λ Response Shows pDCs Express Highest Level of IFN-λR1 and Are Directly Responsive via the JAK-STAT Pathway
2016
Endoplasmic Reticulum Stress Regulates Hepatic Bile Acid Metabolism in Mice
2016
Non-alcoholic fatty liver and the gut microbiota
2016
Long COVID: major findings, mechanisms and recommendations
2023 Standout
Environment and the Inflammatory Bowel Diseases
2013
From NASH to HCC: current concepts and future challenges
2019
Hepatic stellate cells as key target in liver fibrosis
2017
Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review
2011 Standout
Oncology Meets Immunology: The Cancer-Immunity Cycle
2013 Standout
The Toronto Consensus for the Treatment of Helicobacter pylori Infection in Adults
2016
Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome
2015 StandoutNature
IL-1R and MyD88 Contribute to the Absence of a Bacterial Microbiome on the Healthy Murine Cornea
2018 StandoutNobel
Differential Activation of the Transcription Factor IRF1 Underlies the Distinct Immune Responses Elicited by Type I and Type III Interferons
2019
Chronic inflammation in the etiology of disease across the life span
2019 Standout
Differential induction of interferon stimulated genes between type I and type III interferons is independent of interferon receptor abundance
2018
The gut microbiota, bacterial metabolites and colorectal cancer
2014 Standout
Role of the gut microbiota in inflammatory bowel disease pathogenesis: What have we learnt in the past 10 years?
2014
Standard triple, bismuth pectin quadruple and sequential therapies forHelicobacter pylorieradication
2010
Sequential Therapy for Helicobacter pylori Eradication
2010
Antibiotic treatment for Helicobacter pylori : Is the end coming?
2015
A Randomized Controlled Study Comparing Reverse Hybrid Therapy and Standard Triple Therapy for Helicobacter pylori Infection
2015
A Pilot Randomized Controlled Study of Dexlansoprazole MR-Based Triple Therapy for Helicobacter Pylori Infection
2016
Could Helicobacter organisms cause inflammatory bowel disease?
2010
Shared and Distinct Functions of Type I and Type III Interferons
2019
Hepatocellular carcinoma
2021 Standout
Intestinal microbiota and nonalcoholic steatohepatitis
2017
Optimal therapy for Helicobacter pylori infections
2011
Cancer stem cells revisited
2017 Standout
The stomach in health and disease
2015
The Role of the Immune System in Metabolic Health and Disease
2017
Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences
2013 Standout
Role of the Microbiota in Immunity and Inflammation
2014 Standout
Nonalcoholic Fatty Liver Disease: Modulating Gut Microbiota to Improve Severity?
2020
Host Remodeling of the Gut Microbiome and Metabolic Changes during Pregnancy
2012 Standout
Mechanisms of NAFLD development and therapeutic strategies
2018 Standout
Non-alcoholic fatty liver disease
2021 Standout
Interferon Lambda Alleles Predict Innate Antiviral Immune Responses and Hepatitis C Virus Permissiveness
2014 StandoutNobel
Clarithromycin for first-line treatment of Helicobacter pylori infection after culture in high-resistance regions
2014
Guarding the frontiers: the biology of type III interferons
2015
Antimicrobial activity of metals: mechanisms, molecular targets and applications
2013 Standout
The Gut Microbiome in Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS)
2022
Global eradication rates for Helicobacter pylori infection: systematic review and meta-analysis of sequential therapy
2013
Review article: non-bismuth quadruple (concomitant) therapy for eradication of Helicobater pylori
2011
Rational Helicobacter pylori Therapy: Evidence-Based Medicine Rather Than Medicine-Based Evidence
2013
Interferons and viruses: an evolutionary arms race of molecular interactions
2015 StandoutNobel
Prevalence of Antibiotic Resistance in Helicobacter pylori: A Systematic Review and Meta-analysis in World Health Organization Regions
2018 Standout
Differentiated Troy+ Chief Cells Act as Reserve Stem Cells to Generate All Lineages of the Stomach Epithelium
2013
The intestinal epithelial barrier: a therapeutic target?
2016 Standout
Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy
2017 Standout
Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages
2020 Standout
Analysis of the Intestinal Lumen Microbiota in an Animal Model of Colorectal Cancer
2014
Functional Specialization of Interleukin-17 Family Members
2011 Standout
IL-28B is a Key Regulator of B- and T-Cell Vaccine Responses against Influenza
2014 StandoutNobel
Surrogate Wnt agonists that phenocopy canonical Wnt and β-catenin signalling
2017 StandoutNatureNobel
The utility of radiological imaging in nonalcoholic fatty liver disease
2002 Standout
A novel method for detection of IFN-lambda 3 binding to cells for quantifying IFN-lambda receptor expression
2017 Nobel
Commensal bacteria at the interface of host metabolism and the immune system
2013
Differential expression of interferon-lambda receptor 1 splice variants determines the magnitude of the antiviral response induced by interferon-lambda 3 in human immune cells
2020 StandoutNobel
Update on non-bismuth quadruple (concomitant) therapy for eradication of Helicobacter pylori
2012
Intestinal microbiota, evolution of the immune system and the bad reputation of pro-inflammatory immunity
2011
Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies
2017 Standout
IBD—what role do Proteobacteria play?
2012
Lack of Commensal Flora in Helicobacter pylori–Infected INS-GAS Mice Reduces Gastritis and Delays Intraepithelial Neoplasia
2010
Dendritic cell metabolism
2014
Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based triple therapy: a randomised, open-label, non-inferiority, phase 3 trial
2011
Guidelines for treatment ofHelicobacter pyloriin the East and West
2011
The role of neutrophils during intestinal inflammation
2012
Current Concepts, Opportunities, and Challenges of Gut Microbiome-Based Personalized Medicine in Nonalcoholic Fatty Liver Disease
2020
Differential inflammatory response to Helicobacter pylori infection: etiology and clinical outcomes
2015
TH17 cells in tumour immunity and immunotherapy
2010
Cost-effectiveness of screening and treating Helicobacter pylori for gastric cancer prevention
2013
Neutrophil recruitment and function in health and inflammation
2013 Standout
Tumor Necrosis Factor Inhibits Spread of Hepatitis C Virus Among Liver Cells, Independent From Interferons
2017 StandoutNobel
Modeling Development and Disease with Organoids
2016 Standout
Control of adaptive immunity by the innate immune system
2015 Standout
The human skin microbiome
2018 Standout
The human microbiome: at the interface of health and disease
2012 Standout
Globalisation of inflammatory bowel disease: perspectives from the evolution of inflammatory bowel disease in the UK and China
2016
Polybacterial human disease: the ills of social networking
2014
Hepatitis C Virus RNA Functionally Sequesters miR-122
2015 StandoutNobel
Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
2020 Standout
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
A Fibrosis‐Independent Hepatic Transcriptomic Signature Identifies Drivers of Disease Progression in Primary Sclerosing Cholangitis
2020 StandoutNobel
Friend and foe: factors influencing the movement of the bacterium Helicobacter pylori along the parasitism–mutualism continuum
2014
Genetic Variation at IFNL4 Influences Extrahepatic Interferon-Stimulated Gene Expression in Chronic HCV Patients
2017 StandoutNobel
Environmental risk factors for inflammatory bowel disease.
2010
The impact of the interferon-lambda family on the innate and adaptive immune response to viral infections
2014 StandoutNobel
Helicobacter pyloriand Gastric Cancer: Factors That Modulate Disease Risk
2010
Immunometabolism governs dendritic cell and macrophage function
2015 Standout
Regulation of immune cell function by short‐chain fatty acids
2016
Ten day sequential versus 10 day modified bismuth quadruple therapy as empirical firstline and secondline treatment for Helicobacter pylori in Chinese patients: an open label, randomised, crossover trial
2013
Use of a combination formulation of bismuth, metronidazole and tetracycline with omeprazole as a rescue therapy for eradication of Helicobacter pylori
2014
Microbiome-Modulated Metabolites at the Interface of Host Immunity
2017
ICOS+Foxp3+TILs in gastric cancer are prognostic markers and effector regulatory T cells associated withHelicobacter pylori
2016 StandoutNobel
Organogenesis in a dish: Modeling development and disease using organoid technologies
2014 StandoutScience
Introduction to the human gut microbiota
2017 Standout
IFN-λ is able to augment TLR-mediated activation and subsequent function of primary human B cells
2015
Clinical Evaluation of a Ten‐Day Regimen with E someprazole, M etronidazole, A moxicillin, and C larithromycin for the Eradication of H elicobacter pylori in a High Clarithromycin Resistance Area
2013
Lipopolysaccharide and Tumor Necrosis Factor Alpha Inhibit Interferon Signaling in Hepatocytes by Increasing Ubiquitin-Like Protease 18 (USP18) Expression
2016
Plastic and Human Health: A Micro Issue?
2017 Standout
Nonalcoholic Fatty Liver Disease
2019
IFN‐λ‐mediated IL‐12 production in macrophages induces IFN‐γ production in human NK cells
2014
The oral microbiota: dynamic communities and host interactions
2018 Standout
Immune control and failure in HCV infection—tipping the balance
2014
Type III interferons: Balancing tissue tolerance and resistance to pathogen invasion
2019
Antimicrobial Susceptibility‐Guided Therapy Versus Empirical Concomitant Therapy for Eradication of Helicobacter pylori in a Region with High Rate of Clarithromycin Resistance
2015
The role of nutrition in non‐alcoholic fatty liver disease: Pathophysiology and management
2020
Works of Jay Luther being referenced
Kinetic differences in the induction of interferon stimulated genes by interferon-α and interleukin 28B are altered by infection with hepatitis C virus
2013
Alterations in Fecal Microbiomes and Serum Metabolomes of Fatigued Patients With Quiescent Inflammatory Bowel Diseases
2020
Hepatic Injury in Nonalcoholic Steatohepatitis Contributes to Altered Intestinal Permeability
2015
Prior Helicobacter pylori infection ameliorates Salmonella typhimurium-induced colitis
2010
Helicobacter pyloridirects tolerogenic programming of dendritic cells
2010
Association between Helicobacter pylori infection and inflammatory bowel disease
2009
Helicobacter pylori Immune Escape Is Mediated by Dendritic Cell–Induced Treg Skewing and Th17 Suppression in Mice
2009
Intestinal dysbiosis in inflammatory bowel disease
2011
Helicobacter pylori DNA decreases pro-inflammatory cytokine production by dendritic cells and attenuates dextran sodium sulphate-induced colitis
2011
Empiric Quadruple vs. Triple Therapy for Primary Treatment of Helicobacter pylori Infection: Systematic Review and Meta-Analysis of Efficacy and Tolerability
2009
Exposure to human immunodeficiency virus/hepatitis C virus in hepatic and stellate cell lines reveals cooperative profibrotic transcriptional activation between viruses and cell types
2016
Butyrate increases IL-23 production by stimulated dendritic cells
2012
Sequential Therapy for Helicobacter Pylori: A Two for One Deal That's Worth the Extra Effort?
2008